Symbiosis C.M.

Symbiosis C.M.
Medical device company addressing anatomical variability in valvular heart disease.
About
What does Symbiosis C.M. do?
Symbiosis C.M. is an innovative medical device company focused on solving the challenges posed by anatomical variability in valvular heart disease. Their solutions aim to improve the fit and performance of existing medical devices and to create standalone products for anatomies with significant inter-patient variation.
What is Symbiosis C.M.'s revenue?
StartupHub estimates Symbiosis C.M.'s annual revenue at $3.1M (range $601K to $4.8M, 32% confidence), based on comparable companies in the sector.
What is Symbiosis C.M.'s valuation?
StartupHub estimates Symbiosis C.M.'s effective valuation at $37.8M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Symbiosis C.M. raised?
Symbiosis C.M. has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Symbiosis C.M. headquartered?
Symbiosis C.M. is headquartered in Boston, United States.
When was Symbiosis C.M. founded?
Symbiosis C.M. was founded in 2021.
What industry does Symbiosis C.M. operate in?
Symbiosis C.M. operates in Healthcare, Medical Device, MedTech, HealthTech, Medical Devices, Cardiovascular Devices.
No comments yet. Be the first to share your take.
